BPA
GILD icon

Beacon Pointe Advisors’s Gilead Sciences GILD Stock Holding History

Beacon Pointe Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.43M Sell
66,695
-23,036
-26% -$3.04M 0.04% 388
2026
Q1 		$12.5M Buy
89,731
+6,681
+8% +$936K 0.07% 265
2025
Q4 		$10.2M Buy
83,050
+50,598
+156% +$6.15M 0.07% 254
2025
Q3 		$3.6M Sell
32,452
-3,431
-10% -$390K 0.03% 422
2025
Q2 		$3.98M Buy
35,883
+539
+2% +$57.4K 0.04% 360
2025
Q1 		$3.96M Sell
35,344
-1,928
-5% -$199K 0.04% 343
2024
Q4 		$3.44M Sell
37,272
-4,742
-11% -$427K 0.04% 343
2024
Q3 		$3.52M Sell
42,014
-10,340
-20% -$789K 0.04% 360
2024
Q2 		$3.59M Sell
52,354
-1,770
-3% -$118K 0.04% 347
2024
Q1 		$3.96M Sell
54,124
-8,696
-14% -$669K 0.04% 352
2023
Q4 		$5.09M Sell
62,820
-1,164
-2% -$90.6K 0.06% 282
2023
Q3 		$4.8M Buy
63,984
+24,477
+62% +$1.88M 0.06% 268
2023
Q2 		$3.04M Sell
39,507
-13,752
-26% -$1.1M 0.05% 303
2023
Q1 		$4.42M Buy
53,259
+11,267
+27% +$933K 0.08% 230
2022
Q4 		$3.6M Buy
41,992
+6,948
+20% +$550K 0.07% 248
2022
Q3 		$2.16M Buy
35,044
+1,864
+6% +$118K 0.05% 303
2022
Q2 		$2.05M Sell
33,180
-29,884
-47% -$1.85M 0.04% 324
2022
Q1 		$3.75M Buy
63,064
+28,991
+85% +$1.85M 0.05% 309
2021
Q4 		$2.47M Buy
34,073
+5,071
+17% +$349K 0.06% 227
2021
Q3 		$2.03M Buy
29,002
+4,602
+19% +$323K 0.05% 283
2021
Q2 		$1.68M Buy
24,400
+20,864
+590% +$1.39M 0.06% 246
2021
Q1 		$228K Sell
3,536
-1,020
-22% -$65.8K 0.01% 461
2020
Q4 		$265K Buy
+4,556
New +$275K 0.02% 395
2020
Q3 		– Sell
-4,641
Closed -$356K – 410
2020
Q2 		$356K Buy
+4,641
New +$356K 0.04% 279

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beacon Pointe Advisors's GILD Position: Q2 2026 in Review

Beacon Pointe Advisors reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $3.04M and leaving 66,695 shares worth $8.43M. The position accounts for 0.04% of the portfolio, ranked #388.

Beacon Pointe Advisors first reported a position in GILD in Q2 2020 and has held it in 24 quarters since. The position peaked at $12.5M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Beacon Pointe Advisors held 66,695 shares of Gilead Sciences worth $8.43M as of Q2 2026.
  • Beacon Pointe Advisors sold 23,036 Gilead Sciences shares in Q2 2026, an estimated $3.04M.
  • Gilead Sciences made up 0.04% of Beacon Pointe Advisors's portfolio in Q2 2026, its #388 holding.
  • Beacon Pointe Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 24 quarters since.
  • Beacon Pointe Advisors's Gilead Sciences position peaked at $12.5M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.